- DexCom (DXCM) moves up on a solid Q2 earnings beat.
- Product revenue grew 65% Y/Y. Total revenue, which included development grant and other revenue, grew 53% over the same period.
- Product gross profit totaled $21.8M, compared to $10.6M in Q212.
- Shares +12.9% AH.
Next headline on your portfolio: